Brief: Paion - NDA Approval Of Byfavo In South Korea

PAION AG

07/01/2021 10:19

Jan 7 (Reuters) - PAION AG  PA8G.DE :
    * PAION AG: HANA PHARM RECEIVES MARKET APPROVAL FOR
REMIMAZOLAM
(BYFAVO) IN GENERAL ANESTHESIA IN SOUTH KOREA
    * NDA APPROVAL OF BYFAVO^TM IN SOUTH KOREA TRIGGERS A
MILESTONE
PAYMENT OF EUR 1 MILLION FROM HANA PHARM. END OF INSIDE
INFORMATION
    * NDA APPROVAL OF BYFAVO^TM IN SOUTH KOREA TRIGGERS A
MILESTONE
PAYMENT OF EUR 1 MILLION FROM HANA PHARM.

Source text for Eikon:  ID:nEQ6sy2bna 
Further company coverage:  PA8G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))